Concepedia

Marie-Hélène Wasmer

MW

Statistics

Publications

8

Citations

680

H-Index

8

Active since

2013

Affiliations

University of Bern(Current)

University Hospital of Bern

Bern University of Applied Sciences

University Hospital of Zurich

Essen University Hospital

Marie-Hélène Wasmer is an author at University of Bern specializing in oncology, cancer immunotherapy, and tumor immunology.

Publications per year

2013–2024

8

Publications

8

The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer

Eva Pastille, Marie-Hélène Wasmer, Alexandra Adamczyk et al. · Mucosal Immunology · 2019 · 144 citations · Full text

, , +17

Lapatinib and doxorubicin enhance the <scp>S</scp>tat1‐dependent antitumor immune response

Lára Hannesdóttir, Piotr Tymoszuk, Nirmala Parajuli et al. · European Journal of Immunology · 2013 · 114 citations · Full text

, , +17

In situ proliferation contributes to accumulation of tumor‐associated macrophages in spontaneous mammary tumors

Piotr Tymoszuk, Hanneke Evens, Vanessa Marzola et al. · European Journal of Immunology · 2014 · 103 citations

, , +17

The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice

Kirsten D. Mertz, Lukas F. Mager, Marie-Hélène Wasmer et al. · OncoImmunology · 2015 · 93 citations · Full text

, , +17

IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms

Lukas F. Mager, Carsten Riether, Christian M. Schürch et al. · Journal of Clinical Investigation · 2015 · 90 citations · Full text

, , +16

1–5 of 8